Send us Fan Mail

This episode of Our MBC Life features Stephanie Walker and Julia Maués of the Patient-Centered Dosing Initiative team who have been working on the 2025 reboot of its groundbreaking 2020 patient survey. Julia and Stephanie break down how treatment doses are typically determined during clinical trials and why individualized dosing, based on more than your diagnosis, is so important for people living with metastatic breast cancer. They also chat about the newly launched 2025 Patient Dosing Survey that you can take right now, where to find it and why your experience about metastatic breast cancer treatment matters.

Be sure and visit OurMBCLife.org  to check the episode notes for links and more information.

We’re so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you’d like us to cover? Email us at [email protected]. And don’t forget to follow us on our socials @ourmbclife. 

Remember you are not alone.